PHARMACY

NCPA develops LTC advisory board

BY Allison Cerra

ALEXANDRIA, Va. — The National Community Pharmacists Association has created a new advisory board to help the organization’s push to expand long-term care pharmacy programming for its members.

The new group will play a key role in helping the NCPA to address the business impact of proposed government policy on independent pharmacy. Members include:

  • Jim McMackin of Wilson Pharmacy, Johnson City, Tenn.;

  • Dennis Conlin of Conlin’s Pharmacy, Methuen, Mass.;

  • Brian Beach of Kelley-Ross Pharmacy, Seattle;

  • Jim Dunham of Americare, Cookeville, Tenn.;

  • Stephen Carroll of All Care, Arkadelphia, Ark.;

  • Rick Steinhauser of Merwin LTC Pharmacy, Minneapolis;

  • Sharlea Leatherwood of Great Oak Pharmacy, Gladstone, Mo.;

  • Mike Flint of Mallatt Pharmacy, Madison, Wis.;

  • Michele Belcher of Grants Pass Pharmacy, Grants Pass, Ore.;

  • Ryan Beddingfield of United Pharmacy Services, Norcross, Ga.;

  • Russ Zakarian of Model Drug, Kingsburg, Calif.;

  • Paula Perrone of PerroneRx, Fort Worth, Texas;

  • Vernon Massengill of North Village Pharmacy, Yanceyville, N.C.;

  • Mary Ludlow of White Oak Pharmacy, Spartanburg, S.C.;

  • Patty Crawford of LTC Pharmacy Solutions, Richmond, Va.; and

  • Jeff Schneider of Legacy Consultant Pharmacy, Winston-Salem, N.C.

In related news, the NCPA announced that it had reformatted and improved its community-aging, assisted-living and long-term care program to include education opportunities for both beginning and seasoned practitioners.

“[The] NCPA is committed to meeting advocacy needs and providing business solutions to LTC pharmacies, and these are important steps toward that goal,” said Robert Greenwood, NCPA president. “The year 2011 will be filled with challenges and opportunities for LTC pharmacies, and NCPA will give independent long-term care pharmacy providers a strong, clear voice in their communities, Congress, the courts and in federal agencies.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA limits amount of acetaminophen in prescription drugs

BY Alaric DeArment

SILVER SPRING, Md. — The Food and Drug Administration is capping the amount of the painkiller acetaminophen in prescription drugs due to the risk of liver toxicity, the agency said Thursday.

The FDA asked manufacturers of prescription drugs that contain the drug to limit it to 325 mg per tablet. The policy will be phased in over three years but does not affect over-the-counter products containing the drug, such as Johnson & Johnson’s Tylenol and Procter & Gamble’s NyQuil. The drug often appears in prescription painkillers, such as Endo Pharmaceuticals’ Percocet (oxycodone and acetaminophen) and Abbott’s Vicodin (hydrocodone and acetaminophen).

Overdoses from prescription painkillers combining acetaminophen with another ingredient account for nearly half of all cases of acetaminophen-related liver failure, which often result in liver transplant or death, according to the FDA. The risk usually is increased when patients take multiple drugs containing acetaminophen at once and exceed the current maximum dose of 4,000 mg within a 24-hour period.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

‘Unstoppable’ hauls its way to Blu-ray, DVD

BY Allison Cerra

LOS ANGELES — The tale of two courageous men that look to stop a half-mile-long freight train from destroying a city is barreling its way to Blu-ray and DVD, thanks to Twentieth Century Fox Home Entertainment.

"Unstoppable," an action-packed thriller starring Denzel Washington and Chris Pine, will be available Feb. 15. Both formats include several bonus features, including director commentary and script development.

"Unstoppable" on Blu-ray will carry a suggested retail price of $39.99 and will be available on DVD for an SRP of $29.98.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?